mifepristone has been researched along with 2019 Novel Coronavirus Disease in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 24 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, CC; Chen, MJ; Creinin, MD; Hou, MY; Mastey, N; Matulich, MC; Melo, J; Uhm, S; Wilson, SF | 1 |
| Cameron, S; Evans, E; Johnstone, A; McCabe, K; Reynolds-Wright, JJ | 2 |
| Bercu, C; Carbone, S; Egwuatu, I; Gerdts, C; Grosso, B; Jayaweera, R; Kristianingrum, IA; Moseson, H; Motana, R; Nmezi, S; Zurbriggen, R | 1 |
| Barar, R; Biggs, MA; Blanchard, K; Ehrenreich, K; Grossman, D; Kapp, N; Moayedi, G; Morris, N; Perritt, J; Ralph, LJ; Raymond, EG; White, K | 1 |
| Rubin, R | 1 |
| Basky, G; Vogel, L | 1 |
| Boraas, CM; Coplon, L; Gold, M; Kaneshiro, B; Koenig, LR; Raymond, EG; Upadhyay, UD; Winikoff, B | 1 |
| Cameron, S; French, RS; Lewandowska, M; Lohr, PA; Meiksin, R; Palmer, MJ; Reiter, J; Salaria, N; Scott, RH; Wellings, K | 1 |
| Feng, LY; Hsieh, YP; Li, JH; Wang, YJ; Wu, LT | 1 |
| Baker, CN | 1 |
| Adams, KN; Ahmed, SJ; Akaputra, R; Akosman, I; Akya, A; Ali, S; Aminuddin, A; An, B; An, X; Anana, EV; Ao, L; Arany, Z; Arena, R; Azhar, A; Azhar, W; Baasankhuu, A; Bae, WK; Bahar, B; Balaji, L; Barbosa, M; Batchu, UR; Berg, KM; Berlin, N; Berthier, E; Bettiol, AA; Bi, B; Bodie, D; Borges, VF; Borghi-Silva, A; Bowman, CE; Brantly, M; Budhathoki, L; Bukhari, A; Cabeza, M; Cao, J; Cao, Q; Cao, S; Carrasco-Nuñes, N; Caruso, FR; Carvalho, C; Chakrabarty, D; Chandra Mondal, P; Chandran, V; Chang, P; Chase, M; Chauhan, AS; Chauhan, PS; Che, J; Cheemalamarri, C; Chen, D; Chen, H; Chen, J; Chen, Q; Chen, X; Chen, Z; Chetri, BK; Cho, SW; Choi, TI; Chung, HC; Cocchi, MN; Collins, LC; Colombo, N; Come, SE; Custodio, JM; Dai, TY; De La Garza Ramos, R; de Oliveira, CR; Dębczak, A; DeMuri, GP; Deng, J; Deng, K; Dhanani, LY; Diaz, S; Djaharuddin, I; Dong, G; Dong, Q; Donnino, MW; Dwiyanti, R; Elango, KP; Eleswarapu, A; Evans, EGB; Fachri, M; Fang, Y; Fantappiè, G; Farasat, A; Farsida, F; Fathimah, A; Febrianti, A; Feng, S; Fernandes, V; Fernandez Garcia, E; Fleming, GF; Foskett, JK; Fourman, MS; Fu, M; Fu, W; Fukushima, S; Gahlay, GK; Gai, S; Gao, R; Gao, W; Gilbert, DM; Gong, J; Gong, MN; Gong, Z; González-Cavieres, L; Gordon, SE; Goudarzi, F; Goulart, CDL; Greenstein, AE; Grigg, ARC; Grilli, D; Grisham, RN; Grossestreuer, AV; Grzęda, A; Grzegorczyk, A; Gu, J; Guo, H; Gupta, R; Haldar, A; Hamid, Y; Han, HJ; Hancock, CN; Hassan, GW; Hatta, M; He, D; He, F; He, J; Heidarinia, H; Helmchen, G; Herrera-Lavados, C; Hieber, DL; Hoehr, C; Hou, L; Huang, C; Huang, J; Hussain, S; Imaoka, S; Indoliya, Y; Jain, E; Jana, S; Jang, H; Jang, HS; Jara-Quijada, E; Jeacopello, I; Jeung, HC; Jiang, B; Jiang, D; Jiang, G; Jiang, L; Jiang, Q; Jiang, Y; Jiang, Z; Jiao, Z; Jr, JCB; Jung, M; Jung, S; Junita, AR; Kalavathi, A; Kang, X; Kannan, R; Kato, K; Khadka, M; Khan, AR; Khan, I; Khodayari, N; Kim, BJ; Kim, CG; Kim, CH; Kim, D; Kim, H; Kim, HS; Kim, HT; Kim, TS; Kim, YT; King, R; Koh, K; Konkol, M; Koo, DH; Kretzschmar, R; Krop, IE; Kuang, Y; Kubeneck, LJ; Kulkarni, K; Kumar, N; Kunjan, C; Kwon, WS; Lai, C; Lans, A; Lascano, J; Lavania, UC; Lee, CK; Lee, DA; Lee, HS; Lee, J; Lee, KH; Lee, MS; Lee, SW; Lee, UN; Lemus-Mondaca, R; Li, HR; Li, J; Li, Q; Li, X; Li, Y; Li, Z; Liang, H; Liang, Y; Lin, L; Lin, Y; Lipsyc-Sharf, M; Liu, B; Liu, C; Liu, DX; Liu, H; Liu, J; Liu, K; Liu, S; Liu, X; Liu, Z; Locknane, MP; Lorusso, D; Lü, H; Luo, Z; Lv, X; Ma, Y; Mandava, K; Manfrinetti, P; Mao, W; Marques-Sá, J; Masaki, T; Massi, MN; Matsuse, M; Matulonis, UA; Maxwell, CA; McAssey, EV; McManamen, AM; Mehl, RA; Mendes, RG; Meng, Z; Miao, Z; Miller, S; Milovanovic, S; Mishra, SK; Mitra, S; Mitsutake, N; Miyazaki, Y; Moriwaki, S; Mortenson, R; Moskowitz, A; Mudring, AV; Mues Genannt Koers, L; Muhammad, S; Muhimpundu, S; Murapaka, C; Murota, H; Mv, S; Nakazawa, Y; Nam, CM; Natzir, R; Ngo, L; Nguyen, DD; Nie, Y; Nishigori, C; Noji, MC; Notini, L; Oaknin, A; Ogi, T; Oguro, A; Okukawa, K; Olawaiye, AB; Omble, AD; Oso, T; Page, CA; Palma-Acevedo, A; Pani, M; Parikh, SM; Park, J; Park, S; Partridge, AH; Pashova, HI; Paudel, U; Paulssen, E; Payero, L; Peng, M; Peppercorn, JM; Pérez-Won, M; Pitarresi, JR; Pradhan, J; Prevost, D; Primaguna, MR; Puvvada, N; Qian, D; Rajaure, YS; Rajca, A; Rajput, N; Rana, SR; Rangan, L; Ranjbarian, P; Redd, PS; Ren, T; Rha, SY; Riley, L; Romano, M; Rong, X; Rosenberg, SM; Rostamian, M; Rothwell, KA; Ru, S; Ruddy, KJ; Rustgi, AK; Salam, A; Sankaran, S; Santoso, A; Saravanakumar, P; Satheeshkumar, K; Schapira, L; Schulz, K; Senapati, A; Senju, C; Sharma, P; Shelke, RG; Shen, F; Shen, X; Shen, Y; Sheteiwy, MS; Shetty, PR; Shi, L; Shi, MM; Shiigi, H; Shimada, M; Shinkawa, VAM; Shtender, V; Siswanto, FM; Smetana, V; Snow, C; Sridiana, E; Stephenson, MW; Stoll, S; Su, X; Sun, S; Sun, XF; Surapaneni, JR; Suri, K; Świątek, Ł; Syukri, A; Tabilo-Munizaga, G; Takezawa, MG; Tamimi, RM; Tamura, A; Tanaka, K; Tang, M; Tao, Y; Tateishi, S; Thapa, B; Theberge, AB; ThomasArrigo, LK; Thongpang, S; Tiwari, M; Tong, Q; Totton, RR; Tripathi, RD; Tsujimoto, M; Tu, WC; Tudor, IC; Tyskiewicz, K; Ubaidah, FM; Ulhassan, Z; Utani, A; Van Gorp, T; Veerapandian, V; Vennila, KN; von Gunten, U; Wagle, N; Waks, AG; Wald, ER; Wang, B; Wang, D; Wang, H; Wang, L; Wang, W; Wang, X; Wang, Y; Wang, Z; Warner, E; Waterhouse, GIN; Weiss, J; Weissenrieder, JS; Wellen, KE; Wu, JY; Xiang, W; Xiao, S; Xie, Q; Xu, F; Xu, TW; Xu, Y; Yan, B; Yan, JM; Yang, D; Yang, P; Yang, S; Yang, W; Yao, Y; Yassari, R; Yong, Q; Yu, H; Yu, Z; Yun, UJ; Zagotta, WN; Zang, DY; Zanudo, JGT; Zeng, A; Zhang, H; Zhang, R; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YT; Zhao, C; Zhao, J; Zhong, S; Zhou, F; Zhou, W; Zhou, Y | 1 |
| Boyd, K; Grant, M; Koenig, LR; Raymond, EG; Shochet, T; Upadhyay, U; Weaver, MA | 1 |
| Fortin, J; Goldberg, A; Janiak, E; Mokashi, M; Neill, S | 1 |
| Brill, G; Huybrechts, KF; Hwang, CS; Kesselheim, AS; Rome, BN; Sarpatwari, A | 1 |
| Brown, BL; Sarpatwari, A; Wood, SF | 1 |
| Fuleihan, C | 1 |
| Anger, HA; Baldwin, MK; Banks, J; Bednarek, PH; Boraas, CM; Chong, E; Coplon, L; Grant, MS; Haskell, S; Platais, I; Priegue, E; Raidoo, S; Raymond, E; Shochet, T; Soon, R; Thompson, F; Tocce, K; Winikoff, B | 1 |
| Bowen, E; Kaneshiro, B; Kerestes, C; Lacar, L; Murayama, S; Natavio, M; Platais, I; Raidoo, S; Seamon, E; Soon, R; Stowers, P; Tyson, J | 1 |
| Serpico, JJ | 1 |
| Foster, AM; Mark, A; Perritt, J | 1 |
| Aultman, K; Beran, BD; Cirucci, CA; Harrison, DJ; Lockwood, MD; Seiler, S | 1 |
| Boydell, N; Cameron, ST; Harden, J; Reynolds-Wright, JJ | 1 |
| Koenig, LR; Meckstroth, KR; Upadhyay, UD | 1 |
2 trial(s) available for mifepristone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study.
Topics: Abortion, Induced; COVID-19; Dilatation; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, Second; SARS-CoV-2 | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bioaccumulation; Blood Glucose; Brain; Brassica napus; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Catalysis; Child; China; Chlorides; Chlorine; Chromium; Chronic Disease; Cohort Studies; Copper; Corrosion; COVID-19; Creatinine; Dermatitis; Diabetes Mellitus; Diazepam; Disease-Free Survival; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Dyspnea; Electron Spin Resonance Spectroscopy; Environmental Monitoring; Escherichia coli; Escherichia coli Infections; Esophageal Neoplasms; Esophagogastric Junction; Estradiol; Exercise Test; Exercise Tolerance; Female; Ferric Compounds; Fishes; Food Chain; gamma-Aminobutyric Acid; Genomics; Halogenation; HEK293 Cells; Hemolysis; Heterocyclic Compounds; Hospitalization; Humans; Hydrogen Peroxide; Hyperglycemia; Introns; Iron; Kidney; Kinetics; Laboratories; Limit of Detection; Lipopolysaccharides; Liver Neoplasms; Magnesium; Male; Mammals; Materials Testing; Mercury; Metal-Organic Frameworks; Methylmercury Compounds; Mice; Microscopy, Electron, Scanning; Mifepristone; Minerals; Molecular Weight; Mutation; Nanoparticles; Neuroprotection; NF-kappa B; Nitrates; Nitrogen; NLR Family, Pyrin Domain-Containing 3 Protein; Orthopedics; Ovarian Neoplasms; Ovariectomy; Oxidation-Reduction; Oxidative Stress; Oxygen; Oxygen Consumption; Paclitaxel; Phenols; Progesterone; Prospective Studies; Proteins; Protons; Pulmonary Disease, Chronic Obstructive; Ramucirumab; Rats; Receptor, ErbB-2; Respiratory Function Tests; Retrospective Studies; Saliva; SARS-CoV-2; Seeds; Sesbania; Shock, Septic; Silicon Dioxide; Sleep; Soil; Specimen Handling; Spectroscopy, Mossbauer; Spin Labels; Staphylococcus aureus; Stomach Neoplasms; Streptococcus mutans; Thiamine; Toll-Like Receptor 2; Toll-Like Receptor 4; Trastuzumab; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Water; Water Pollutants, Chemical; Water Purification; Xeroderma Pigmentosum; Zebrafish | 2023 |
22 other study(ies) available for mifepristone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
Topics: Abortion, Induced; Anti-Bacterial Agents; Antiemetics; COVID-19; Female; Headache; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Prevalence; Prospective Studies; Referral and Consultation; Telemedicine; Telephone | 2022 |
Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.
Topics: Abortifacient Agents; Abortion, Induced; Argentina; Cohort Studies; COVID-19; Female; Humans; Mifepristone; Misoprostol; Nigeria; Pregnancy; Prospective Studies; Self Administration; Self-Management; Surveys and Questionnaires | 2022 |
Accuracy of self-assessment of gestational duration among people seeking abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Assessment | 2022 |
Expanding Access to Medication Abortions.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; COVID-19; Criminal Law; Drug Prescriptions; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pandemics; Pharmaceutical Services, Online; Pharmacists; Pregnancy; Pregnancy Trimester, First; Risk Evaluation and Mitigation; Self Administration; Self Medication; Self-Management; Telemedicine; United States; United States Food and Drug Administration; Young Adult | 2022 |
How the pandemic is transforming abortion access.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Canada; COVID-19; Female; Health Services Accessibility; Humans; Mifepristone; Pandemics; Pregnancy; Surveys and Questionnaires; Telemedicine | 2022 |
Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
Topics: Abortion, Induced; Abortion, Spontaneous; Cohort Studies; COVID-19; Female; Humans; Mifepristone; Pandemics; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2022 |
Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic.
Topics: COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; United Kingdom | 2022 |
Mifepristone (RU-486
Topics: Abortion, Induced; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mifepristone; Pandemics; Pregnancy; Public Policy; Women's Health | 2022 |
History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion.
Topics: Abortion, Induced; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Politics; Pregnancy; Self-Management; Telemedicine; United States | 2023 |
Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; Retrospective Studies; United States | 2023 |
Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA.
Topics: Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Humans; Massachusetts; Mifepristone; Pandemics; Pregnancy; United States | 2023 |
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis.
Topics: Abortion, Induced; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Mifepristone; Pandemics; Pregnancy; United States | 2023 |
Ensuring Safe Access to Mifepristone During the Pandemic and Beyond.
Topics: Abortion, Induced; COVID-19; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Pandemics; Pregnancy | 2021 |
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; COVID-19; Female; Health Services Accessibility; Humans; Mifepristone; Pandemics; Pregnancy; Reproductive Rights; United States; United States Food and Drug Administration | 2020 |
Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic.
Topics: COVID-19; Female; Humans; Mifepristone; Pandemics; Pregnancy; Prospective Studies; Referral and Consultation; SARS-CoV-2; Telemedicine; Telephone | 2021 |
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; COVID-19; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Postal Service; Pregnancy; SARS-CoV-2; Telemedicine; United States; Young Adult | 2021 |
Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Aftercare; COVID-19; Female; Hawaii; Humans; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Retrospective Studies; Telemedicine; Ultrasonography, Prenatal | 2021 |
Abortion exceptionalism and the mifepristone REMS.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; COVID-19; Drug and Narcotic Control; Humans; Mifepristone; Politics; Risk Evaluation and Mitigation; SARS-CoV-2; Telemedicine; United States; United States Food and Drug Administration | 2021 |
The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Ambulatory Care Facilities; COVID-19; Health Services Accessibility; Humans; Mifepristone; Postal Service; Risk Evaluation and Mitigation; SARS-CoV-2; Telemedicine; United States | 2021 |
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; SARS-CoV-2 | 2021 |
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; COVID-19; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Qualitative Research; SARS-CoV-2; Scotland; Self Administration; State Medicine; Telemedicine | 2021 |
Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic.
Topics: Abortifacient Agents; Abortion, Induced; Adult; COVID-19; Female; Humans; Mifepristone; Pandemics; Patient Safety; Pregnancy; SARS-CoV-2; Telemedicine; Treatment Outcome; United States; Young Adult | 2021 |